Sciensano has updated its guidelines for the treatment of patients diagnosed with the coronavirus. The use of hydroxychloroquine, a drug against malaria, is now strongly discouraged.
Read also Effective and controversial, the chloroquine of the Pr Raoult
The research institute is based on the recent observations on the use of hydroxychloroquine on patients with coronavirus. These show consistently that it does not offer any advantage, and may even have adverse effects. “It has been decided to no longer recommend the use of off-label use for an indication or group of patients for which the drug has not been saved, editor’s note) for COVID-19 in Belgium “, is it stated in the guideline is appropriate.
